Suppr超能文献

改善对患有呼吸窘迫的极低出生体重儿表面活性剂缺乏症的预测。

Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress.

作者信息

Harker L C, Merritt T A, Edwards D K

机构信息

Department of Pediatrics, University of California, Davis.

出版信息

J Perinatol. 1992 Jun;12(2):129-33.

PMID:1522430
Abstract

With the availability of exogenous surfactant therapy, distinguishing between surfactant deficiency and other causes of respiratory distress soon after birth is critical. Of 149 very low-birthweight (VLBW) infants of 24 to 30 weeks' gestation, 107 (72%) had both clinical and radiographic features of respiratory distress syndrome (RDS). Analysis of amniotic fluid obtained within 24 hours before birth or of the initial tracheal aspirate after birth for phosphatidylglycerol (PG) showed that absence of PG had a positive predictive value (PPV) of 80% for predicting RDS, while an immature lecithin/sphingomyelin (L/S) ratio had a PPV of 86% with a 68% specificity. When PG was absent and the L/S ratio was immature, the PPV for RDS increased to 89% (97% specificity). Phospholipid analysis was superior to gestational age alone in predicting RDS (P less than or equal to .02). Receiver operating characteristic (ROC) analysis detected different thresholds for immature L/S ratios for amniotic fluid (2.0) and initial tracheal aspirate (3.0) for predicting RDS. A tracheal aspirate L/S ratio less than or equal to 3.0 predicted RDS with 91% accuracy, while an amniotic fluid L/S ratio less than or equal to 2.0 predicted RDS with 90% accuracy. ROC curve thresholds for either tracheal aspirate or amniotic fluid permit selection of VLBW infants most likely to benefit from surfactant treatment. These analyses improve the accuracy of diagnosing surfactant-deficiency-associated RDS using only clinical and radiographic diagnoses, and may permit a more focused approach for rescue surfactant therapy in infants presenting with clinical symptoms of respiratory distress.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

随着外源性表面活性剂疗法的出现,在出生后不久区分表面活性剂缺乏与其他呼吸窘迫原因至关重要。在149例妊娠24至30周的极低出生体重(VLBW)婴儿中,107例(72%)具有呼吸窘迫综合征(RDS)的临床和影像学特征。对出生前24小时内获取的羊水或出生后最初的气管吸出物进行磷脂酰甘油(PG)分析显示,PG缺失对预测RDS的阳性预测值(PPV)为80%,而卵磷脂/鞘磷脂(L/S)比值不成熟时PPV为86%,特异性为68%。当PG缺失且L/S比值不成熟时,RDS的PPV增至89%(特异性为97%)。磷脂分析在预测RDS方面优于单纯的胎龄(P≤0.02)。受试者工作特征(ROC)分析检测到羊水(2.0)和最初气管吸出物(3.0)中L/S比值不成熟用于预测RDS的不同阈值。气管吸出物L/S比值≤3.0预测RDS的准确率为91%,而羊水L/S比值≤2.0预测RDS的准确率为90%。气管吸出物或羊水的ROC曲线阈值有助于选择最可能从表面活性剂治疗中获益的极低出生体重婴儿。这些分析提高了仅使用临床和影像学诊断来诊断表面活性剂缺乏相关RDS的准确性,并可能为出现呼吸窘迫临床症状的婴儿进行救援性表面活性剂治疗提供更有针对性的方法。(摘要截短于250字)

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验